© 2021 BioMarin. All rights reserved.

A dynamic cross section of business, clinical and biotechnical expertise with a proven track record of providing rapid access to breakthrough therapeutics.

Under the leadership of Chairman and Chief Executive Officer, Mr. Jean-Jacques Bienaimé, BioMarin’s executive management team includes accomplished leaders with deep and broad executive experience. Supported by a staff of approximately 3,000 employees worldwide, we are focused on delivering first-in-class and best-in-class therapeutics to patients with rare genetic diseases.

Leadership Team

  • Jean-Jacques Bienaimé
    Chairman and Chief Executive Officer
  • Henry J. Fuchs
    M.D., President, Worldwide Research & Development
  • Jeff Ajer
    Executive Vice President, Chief Commercial Officer
  • G. Eric Davis
    Executive Vice President, General Counsel and Secretary
  • C. Greg Guyer
    Ph.D., Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
  • Brian R. Mueller
    Executive Vice President, Chief Financial Officer
  • Lon Cardon
    Ph.D., Senior Vice President, Chief Scientific Strategy Officer
  • Philip Lo Scalzo
    Senior Vice President, Chief Compliance Officer
  • Amy Wireman
    Senior Vice President, Human Resources
  • Brinda Balakrishnan
    M.D., Ph.D., Group Vice President, Corporate and Business Development
About Us

Our purpose is the patient. Our passion is the science.

Learn More about us